Mei-Zhu Hong
Overview
Explore the profile of Mei-Zhu Hong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
A significant and persistent rise in the global burden of adolescent NAFLD and NASH estimated by BMI
Lin X, Li J, Huang L, Lin L, Hong M, Weng S, et al.
Front Public Health
. 2024 Nov;
12:1437432.
PMID: 39525454
Background: Currently, there is a lack of global or even country/regional level data on adolescent non-alcoholic fatty liver disease (NAFLD) prevalence. However, an evidenced dose-dependent relationship exists between body mass...
2.
Dong X, Li J, Lu X, Lin X, Hong M, Weng S, et al.
Transl Gastroenterol Hepatol
. 2024 Aug;
9:33.
PMID: 39091655
Background: At present, there is a dearth of comprehensive data at the global, national, and regional levels regarding the adult non-alcoholic fatty liver disease (NAFLD) prevalence. This cross-sectional study aims...
3.
Dong X, Gong L, Hong M, Pan J
BMC Gastroenterol
. 2024 Feb;
24(1):77.
PMID: 38373892
Background: Several studies have found that primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD) are closely associated. However, the direction and causality of their interactions remain unclear. Thus, this...
4.
Zeng D, Chen Z, Hong M, Jiang L, Chen X, Xue H, et al.
J Med Virol
. 2023 Jul;
95(8):e28979.
PMID: 37522253
Traditional Chinese medicine (TCM) is often used as an adjuvant or alternative therapy for abnormal liver biochemistry or liver fibrosis associated with chronic hepatitis B (CHB). However, the role of...
5.
Xing Q, Li J, Chen Z, Lin X, You Y, Hong M, et al.
Med
. 2023 Mar;
4(3):168-181.e3.
PMID: 36868237
Background: Non-alcoholic fatty liver disease (NAFLD) is usually accompanied by metabolic syndrome, which is associated with increased risk of cancer. To inform a tailored cancer screen in patients at higher...
6.
Dong X, Zeng D, Xing Q, Hong M, Pan J
World J Hepatol
. 2023 Jan;
14(12):2012-2024.
PMID: 36618330
Background: Coronavirus disease (COVID-19) patients exhibit different patterns of liver impairment, according to growing evidence. Aim: In this study, we sought to provide a comprehensive analysis of liver test parameters...
7.
Hong M, Li J, Chen Z, Lin X, Pan J, Gong L
Front Oncol
. 2022 Nov;
12:942035.
PMID: 36387124
Background: To understand the impact of common cancers of the gastrointestinal tract and help to formulate evidence-based policy, we evaluate the relationship between the burden of GI tract cancers and...
8.
Hong M, Qiu R, Chen W, Lin H, Xing Q, Dong X, et al.
BMC Infect Dis
. 2022 Sep;
22(1):728.
PMID: 36076167
Background: This study compared clinical features of the Delta variant of coronavirus disease 2019 (COVID-19) in children and adults. Methods: Clinical data included 80 children and 132 adults with the...
9.
Chen W, Fu M, Zhang C, Xing Q, Zhou F, Lin M, et al.
Front Med (Lausanne)
. 2022 May;
9:853261.
PMID: 35530044
Background And Aims: We aim to develop a diagnostic tool for pathological-image classification using transfer learning that can be applied to diverse tumor types. Methods: Microscopic images of liver tissue...
10.
Zeng D, Li J, Lin S, Dong X, You J, Xing Q, et al.
J Hepatol
. 2021 May;
75(3):547-556.
PMID: 33961940
Background & Aims: Acute viral hepatitis (AVH) represents an important global health problem; however, the progress in understanding AVH is limited because of the priority of combating persistent HBV and...